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Introduction
Juvenile idiopathic arthritis (JIA) is the most common
cause of chronic anterior uveitis in childhood, and uvei-
tis is the most frequent extra-articular manifestation
seen overall in children with JIA. Although it is well-
known that ocular involvement is strongly associated
with a constellation of particular clinical features, which
include the presence of antinuclear antibodies (ANA),
young age at disease onset, female sex, and an asym-
metric pattern of arthritis, the relative importance of
each risk factor is still a matter of debate.
Objectives
The aim of the study is to investigate the predictive role
of the main risk factors for chronic anterior uveitis in
Italian children with JIA.
Methods
The clinical charts of all consecutive JIA patients with
the ILAR categories characterized by a distinctive risk
of chronic anterior uveitis (persistent oligoarthritis,
extended oligoarthritis, rheumatoid factor-negative
polyarthritis, psoriatic arthritis and undifferentiated
arthritis) followed by study investigators between 1985
and 2012 were reviewed. Patients with at least two
ANA positive determinations (title ≥1:160) where con-
sidered ANA-positive. Survival analyses, with the first
occurrence of uveitis as the event of interest, were
conducted by means of the Kaplan-Meier method.
Survival curves were compared by the log-rank test.
Factors significantly associated with time to uveitis
onset were then tested in a Cox proportional hazards
regression model.
Results
A total of 1,260 JIA patients were included in the study.
Four patient were excluded due to occurrence of uveitis
before onset of JIA. A total of 278 patients (22.1%)
developed uveitis. No association was found between
the risk of developing uveitis and patient gender (p =
0.70) or ILAR category (p = 0.49), whereas the risk of
developing uveitis was significantly associated with dis-
ease onset before 3.5 years (p < 0.0001) and with posi-
tive ANA (p < 0.0001). The predictive role of the
positive ANA status and of a younger age at onset was
confirmed by Cox proportional hazard regression
analysis.
Conclusion
In a large cohort of JIA patients, we found that the risk
of uveitis was associated with a positive ANA status and
an age at onset ≤ 3.5 years. No association was found
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